Compare BridgeBio Pharma Inc (BBIO) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Sunrun Inc — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Sunrun Inc trades at $12.83 (market cap $2.96B). The key difference: BridgeBio Pharma Inc is far larger — about 5.5× Sunrun Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | RUN | |
|---|---|---|
Market Cap | $16.27B | $2.96B |
Sector | Health | Technology |
52-Week High | $90.17 | $21.41 |
52-Week Low | $44.81 | $9.07 |
Enterprise Value | $17.82B | $17.16B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
